HCA Healthcare (NYSE:HCA) was downgraded by equities research analysts at Bank of America from a “neutral” rating to an “underperform” rating in a research report issued on Thursday. They presently have a $90.00 price objective on the stock, down from their prior price objective of $94.00. Bank of America’s target price points to a potential upside of 3.40% from the stock’s current price.
Several other equities research analysts have also commented on the company. Goldman Sachs Group assumed coverage on HCA Healthcare in a research note on Wednesday. They set a “neutral” rating for the company. Piper Jaffray Companies lowered HCA Healthcare from an “overweight” rating to a “neutral” rating and set a $81.00 price objective for the company. in a research note on Wednesday. Credit Suisse Group reiterated an “outperform” rating and set a $25.00 price objective on shares of HCA Healthcare in a research note on Tuesday, December 26th. SunTrust Banks set a $105.00 price objective on HCA Healthcare and gave the stock a “buy” rating in a research note on Thursday, December 21st. Finally, Morgan Stanley lowered HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $85.00 price objective for the company. in a research note on Wednesday, December 20th. Three analysts have rated the stock with a sell rating, six have given a hold rating and eighteen have given a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $87.60.
HCA Healthcare (NYSE:HCA) traded down $2.47 during midday trading on Thursday, reaching $87.04. The company had a trading volume of 2,402,100 shares, compared to its average volume of 2,114,500. The firm has a market cap of $31,440.00, a PE ratio of 12.38, a price-to-earnings-growth ratio of 1.20 and a beta of 0.55. HCA Healthcare has a 12 month low of $71.18 and a 12 month high of $91.03. The company has a quick ratio of 1.41, a current ratio of 1.68 and a debt-to-equity ratio of -6.46.
In other news, SVP Victor L. Campbell sold 8,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 8th. The stock was sold at an average price of $78.00, for a total value of $624,000.00. Following the completion of the sale, the senior vice president now directly owns 127,275 shares in the company, valued at $9,927,450. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Michael S. Cuffe sold 2,400 shares of the company’s stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $86.63, for a total value of $207,912.00. The disclosure for this sale can be found here. Insiders sold 22,700 shares of company stock valued at $1,773,872 over the last 90 days. Company insiders own 2.90% of the company’s stock.
Hedge funds have recently bought and sold shares of the company. Northwestern Mutual Wealth Management Co. grew its position in HCA Healthcare by 14.0% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,163 shares of the company’s stock worth $101,000 after acquiring an additional 143 shares during the period. Bronfman E.L. Rothschild L.P. grew its position in HCA Healthcare by 35.1% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 1,232 shares of the company’s stock worth $107,000 after acquiring an additional 320 shares during the period. Atlantic Trust LLC purchased a new position in HCA Healthcare in the second quarter worth approximately $118,000. Acrospire Investment Management LLC grew its position in HCA Healthcare by 14.3% in the second quarter. Acrospire Investment Management LLC now owns 1,600 shares of the company’s stock worth $140,000 after acquiring an additional 200 shares during the period. Finally, BB&T Investment Services Inc. purchased a new position in HCA Healthcare in the second quarter worth approximately $141,000. Institutional investors and hedge funds own 75.34% of the company’s stock.
HCA Healthcare Company Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.